While cases of COVID-19 and respiratory syncytial virus (RSV) were decreasing across the United States, infections of another respiratory virus, called human metapneumovirus (HMPV), were increasing during spring.
RELATED:
The percentage of tests positive for HMPV surged to 17.5 percent for antigen tests and 9.6 percent for PCR tests at the end of March, according to the U.S. Centers for Disease Control and Prevention (CDC).
During the four years before the pandemic, the weekly percentage of HMPV positive tests never reached higher than 7.7 percent.
Discovered in 2001, HMPV is in the Pneumoviridae family along with RSV. Broader use of molecular diagnostic testing has increased identification and awareness of HMPV as an important cause of upper and lower respiratory infection.
What is #HMPV, respiratory virus creating havoc in US?
Does India need to worry?#HumanMetaPneumoVirushttps://t.co/b0IwjQt3nQ
— DNA (@dna)
June 1, 2023
HMPV can cause upper and lower respiratory disease in people of all ages, especially among young children, older adults, and people with weakened immune systems.
Surveillance data from CDC’s National Respiratory and Enteric Virus Surveillance System shows HMPV to be most active during late winter and spring in temperate climates.
Symptoms commonly associated with HMPV include cough, fever, nasal congestion, and shortness of breath, according to information on the CDC website.
#Health | 40 years ago, a team from the Pasteur Institute in France discovered the virus that causes AIDS, a milestone that marked the first stage in the fight against a pandemic that has left over 40 million people dead. pic.twitter.com/GJ0kxm8pkY
— teleSUR English (@telesurenglish)
May 12, 2023
